Not Signed In - Data Published In AIDS Show Viramune (nevirapine) Achieves Durable Benefit In Switch Patients
Mon, 05 Feb 2007 08:00 AM EST
... Long-term data from the Nevirapine/Efavirenz/Abacavir (NEFA) study demonstrate that patients who switched from a protease inhibitor-based regimen to a non-nucleoside reverse transcriptase inhibitor-based regimen containing Viramune (nevirapine) or efavirenz achieved comparable efficacy and safety to [click link for full article] ...
Related Topics
- Nevirapine
- Data & Statistics
- Data Analysis
- Hearing Aids
- Nevirapine Oral Suspension
- HIV/AIDS & STDs
- National Data
- Vaccinations For HIV/AIDs Patients
- Acquired Immune Deficiency Syndrome
- AIDS - Living and Coping
- Pediatric Aids
- AIDS and Infections
- AIDS and Pregnancy
- Mining
- Levocarnitine Oral
- Seizures (in about half of patients)
- What Your Female Patients Want to Know About Bladder Control
- Smoking Cessation and Continued Risk in Cancer Patients
- AIDS-Related Cancers
- Definity
email this page
print this page
bookmark this page
feedback on this page
